Target intelligence / Profile preview

Lens fiber major intrinsic protein (AQP0)

Target
AQP0
Molecular classification
Aquaporin family (water channel/transporter), Ion channel (based on sequence and structural classification)[1][3], Integral membrane protein
01

Overview

Lens fiber major intrinsic protein (AQP0) is the principal membrane protein in lens fiber cells, essential for maintaining lens transparency and homeostasis. As a member of the aquaporin family, it functions primarily as a water channel, enabling controlled water flux through lens fiber cell membranes. Unlike other aquaporins, its water permeability is lower and tightly regulated by post-translational modifications and interactions with proteins like calmodulin. Besides water transport, AQP0 acts as an adhesive molecule, forming cell–cell junctions crucial for lens spatial organization and stability. Disruption of AQP0’s function—by genetic mutation or abnormal post-translational changes—leads to impaired lens fiber cell communication and morphology, resulting in congenital cataract and other lens defects. AQP0 is not considered a therapeutic target, as there are currently no drugs in clinical use targeting this protein[1][2][3][4][5].

Other names
Aquaporin-0MIPMIP26MP26LIM1CTRCT15Aquaporin-CHIPmajor intrinsic protein of lens fiberlens fiber major intrinsic protein
02

Mechanism of action

Not applicable; there are no approved drugs acting directly via AQP0. Basic mechanisms if targeted would include modulation of water transport or interference with cell–cell adhesion[1][2]

03

Biological functions

Water transport (channel function)[1][2][4]Cell–cell adhesion (structural maintenance and formation of junctions between lens fibers)[2][4]Lens transparency and homeostasis[1][2][3]Intracellular communication[3]Lens cell differentiation, morphogenesis, and biomechanical integrity[2]
04

Disease associations

Congenital cataract (mutation or deficiency disrupts water transport or cell adhesion, resulting in lens opacity)[1][2]Other lens diseases (impaired lens development, transparency, or morphology)[2]
05

Safety considerations

Theoretical risks relate to impaired lens water homeostasis or cell adhesion resulting in visual impairment or cataract if function disrupted[1][2]No clinical drug safety challenges as it is not a drug target
06

Biomarkers

MIP/AQP0 mutation or expression loss associated with diagnosis and screening for congenital cataract or lens developmental disorders[1][2]Used in research for lens transparency and developmental studies[1][2]

Beyond the preview

Go deeper on Lens fiber major intrinsic protein (AQP0).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lens fiber major intrinsic protein (AQP0).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call